Insider Transactions in Q2 2023 at Tcr2 Therapeutics Inc. (TCRR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Tang Kevin C |
SELL
Other acquisition or disposition
|
Indirect |
4,394,800
-100.0%
|
-
|
|
Jun 01
2023
|
Ansbert Gadicke Director |
SELL
Other acquisition or disposition
|
Indirect |
7,529,946
-100.0%
|
-
|
|
Jun 01
2023
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
4,158,964
-100.0%
|
-
|
|
Jun 01
2023
|
Mpm Sun States Fund, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
4,158,964
-100.0%
|
-
|
|
Jun 01
2023
|
Ubs Oncology Impact Fund L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
3,370,982
-100.0%
|
-
|
|
Jun 01
2023
|
Alfonso Quintas Cardama Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
109,459
-100.0%
|
-
|
|
Jun 01
2023
|
Peter Olagunju Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,092
-100.0%
|
-
|
|
Jun 01
2023
|
Angela Justice Chief People Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
48,745
-100.0%
|
-
|
|
Jun 01
2023
|
Garry E Menzel President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
138,871
-100.0%
|
-
|
|
Jun 01
2023
|
Garry E Menzel President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
265,459
-100.0%
|
-
|
|
May 25
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.12%
|
$50,000
$1.72 P/Share
|
|
May 22
2023
|
Ansbert Gadicke Director |
SELL
Open market or private sale
|
Indirect |
70,170
-18.75%
|
$70,170
$1.88 P/Share
|
|
May 22
2023
|
Ansbert Gadicke Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
178,269
+32.27%
|
$0
$0.74 P/Share
|
|
May 22
2023
|
Mpm Asset Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
70,170
-18.75%
|
$70,170
$1.88 P/Share
|
|
May 22
2023
|
Mpm Asset Management LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
178,269
+32.27%
|
$0
$0.74 P/Share
|
|
May 12
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
6,183
+0.14%
|
$6,183
$1.95 P/Share
|
|
May 11
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
38,765
+0.89%
|
$38,765
$1.95 P/Share
|
|
May 10
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
6,774
+0.16%
|
$6,774
$1.95 P/Share
|
|
May 09
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
20,141
+0.47%
|
$20,141
$1.95 P/Share
|
|
May 08
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
57,073
+1.32%
|
$57,073
$1.95 P/Share
|
|
May 05
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
166,823
+1.96%
|
$166,823
$1.92 P/Share
|
|
May 04
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
104,241
+2.51%
|
$104,241
$1.86 P/Share
|
|
May 03
2023
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
18,513
+0.47%
|
$18,513
$1.85 P/Share
|